Bod Australia filled 755 prescriptions for its MediCabilis product range in October, 60% of which were repeats. 

October prescription volumes represent a 106% increase on the average monthly volumes since July 2019, giving Bod a 57% share of the Australian CBD market.

Bod has now filled 4,400 prescriptions since January this year, which marks a 124% increase on last year’s total of 1,959 prescriptions.

Bod CEO Jo Patterson said: “Strong demand for our MediCabilis product range in Australia will continue to add to our growing revenue profile and we are confident that sales will continue to increase.”